Skip to main content Back to Top
Advertisement

What Happens in Vegas... Stays MSSA-Free? Ceftriaxone vs. Cefazolin for MSSA Management

Broadcast Date: January 14, 2026


ABOUT THIS PODCAST

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode debates the real clinical differences between ceftriaxone and cefazolin for MSSA infections. They challenge common assumptions, break down the latest evidence, and deliver practical pearls every clinician can use tomorrow. Tune in for sharp insights, spirited discussion, and a verdict that might just change your practice.

SPEAKERS

  • Kyle Robb, PharmD
    Director, State Policy & Advocacy, ASHP
  • Kevin Nguyen, PharmD, BCIDP
    Clinical Pharmacy Specialist, Infectious Disease, St. Christopher's Hospital for Children
    Assistant Clinical Professor, Drexel University Physician Assistant Department
  • Hunter Rondeau, PharmD, BCIDP, AAHIVP
    Regional Antimicrobial Stewardship Coordinator, SSM Health DePaul Hospital
    Adjunct Clinical Assistant Professor, University of Kansas School of Pharmacy

LISTEN ON


iTunes      Google            Spotify      TuneIn      iHeart Radio


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP 2020 Summer Sessions

ASHP Pharmacy Futures 2024

Welcome to our new format!
Start Here
Link the whole card
Prescriptions

Drug Shortages

Your first stop for information and resources on drug products, their availability, and management
Learn More
Link the whole card